Defecetive Drugs: adrugrecall.com
NEWSLETTER®
- Accutane®
- Advair®
- Avandia®
- Bextra®
- Botox®
- Byetta®
- CellCept®
- Chantix®
- Cipro®
- Crestor®
- Digitek®
- Duragesic Patch®
- Fleet Phospho Soda®
- Floxin®
- Fluoroquinolone
- Fosamax®
- Gardasil®
- Heparin®
- Hydroxycut®
- Levaquin®
- MRI Dye
- Neurontin®
- Noroxin®
- Nuvaring®
- Ortho Evra®
- Paxil®
- Permax®
- PTU
- Raptiva®
- Reglan®
- Risperdal®
- Serevent®
- Seroquel®
- Trasylol®
- Viagra®
- Vioxx®
- Yasmin®
- Zelnorm®
- Zicam®
- Zyprexa®
Contact Us Today
Use this form to request a free consultation with a qualified attorney near you.
ATTORNEY ADVERTISING -
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
Company challenges FDA ephedra ban
-May 4, 2004
The FDA issued an ephedra recall in December 2003 after the supplements were linked to 155 deaths. Now, Nutraceutical Corporation and its subsidiary Solaray have filed federal lawsuits against the FDA claiming its products are safe because it only contains low doses of ephedra.
Ephedra side effects have been suffered without exceeding recommended amounts. Adverse event reports received for ephedra use has exceeded all other dietary supplements combined. Ephedra users have suffered death, stroke, arrhythmia, heart attacks, chest pain, seizures and hypertension.
For more information on the ephedra recall, please contact us.
view more of this month's articles
- Popular Drug Recalls: Avandia®
- Yaz® Birth Control
- NuvaRing®
- Reglan®
- Home
- Drug Index
- News Archive
- Resources